Suppr超能文献

缺血再灌注损伤、心肌顿抑与心脏预处理之间的关系。

The relationship between ischemia-reperfusion injury, myocardial stunning and cardiac preconditioning.

作者信息

Mitchell M B, Winter C B, Banerjee A, Harken A H

机构信息

University of Colorado Health Sciences Center, Department of Surgery, Denver.

出版信息

Surg Gynecol Obstet. 1993 Jul;177(1):97-114.

PMID:8322165
Abstract

The high incidence of coronary disease in the current population renders myocardial ischemia a leading cause of morbidity and death. Recent efforts have made rapid restoration of coronary flow a clinical reality. Despite progress in hypothermic arrest and cardioplegia, the widespread performance of open cardiac operation and increasing use of cardiac transplantation obligate myocardial I/R stress. Advances in understanding the pathophysiologic factors of reversible and irreversible I/R injury have been significant, but are incomplete. Myocardial infarction and myocardial "stunning" remain clinically important sequelae of coronary disease. In the long term, the solution to heart disease will likely come through preventative health measures. In the interim, however, measures to limit ischemic duration and prepare the heart for reperfusion are clinically desirable. The presence of intrinsic cellular protective mechanisms intimate the feasibility of the latter measure. Furthermore, recently delineated receptor-mediated mechanisms of ischemic preconditioning may render this phenomenon clinically exploitable. The multifactorial pathophysiologic nature of the I/R process suggests that optimal intervention will likely require a combination of pharmacologic adjuncts intended for the specific type and severity of I/R insult. Continued exploration of I/R pathophysiologic factors is needed to develop practical therapeutic interventions.

摘要

当前人群中冠心病的高发病率使心肌缺血成为发病和死亡的主要原因。最近的努力已使冠状动脉血流的快速恢复成为临床现实。尽管在低温停搏和心脏停搏液方面取得了进展,但心脏直视手术的广泛开展以及心脏移植的日益增多使得心肌缺血/再灌注应激不可避免。在理解可逆性和不可逆性缺血/再灌注损伤的病理生理因素方面已取得重大进展,但仍不完整。心肌梗死和心肌“顿抑”仍是冠心病临床上重要的后遗症。从长远来看,心脏病的解决方案可能来自预防性健康措施。然而,在此期间,限制缺血持续时间并使心脏为再灌注做好准备的措施在临床上是可取的。内在细胞保护机制的存在表明后一种措施是可行的。此外,最近阐明的缺血预处理的受体介导机制可能使这一现象在临床上得以应用。缺血/再灌注过程的多因素病理生理性质表明,最佳干预可能需要针对缺血/再灌注损伤的特定类型和严重程度联合使用药物辅助手段。需要继续探索缺血/再灌注病理生理因素以开发切实可行的治疗干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验